drugset / Trial / NCT03038711
A Multiple Dose Study to Assess the Safety and Tolerability of BMS-986166 in Healthy Volunteers
RandomizedParallel-groupDouble-blindScreening
Summary
The purpose of this study is to understand if multiple oral doses of BMS-986166 are safe and well tolerated in healthy patients.
Timeline
- Start
- 2017-02-01
- Primary completion
- 2017-08-10
- Completion
- 2017-08-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BMS-986166 | Small molecule | 0.25 mg | Oral |
| Subject | BMS-986166 | Small molecule | 0.75 mg | Oral |
| Subject | BMS-986166 | Small molecule | 1.5 mg | Oral |